Effect of introducing biologics to patients with rheumatoid arthritis on the risk of venous thromboembolism: a nationwide cohort study

In the United States, 100,000–300,000 patients die from venous thromboembolism (VTE) each year, with more than 500,000 people related hospitalizations. While in Europe, 500,000 people die from VTE each year. Patients with rheumatoid arthritis are at increased risk of VTE. The use of biologics in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chao-Ping, Kung, Pei-Tseng, Chou, Wen-Yu, Tsai, Wen-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382764/
https://www.ncbi.nlm.nih.gov/pubmed/34426637
http://dx.doi.org/10.1038/s41598-021-96508-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382764/
https://www.ncbi.nlm.nih.gov/pubmed/34426637
http://dx.doi.org/10.1038/s41598-021-96508-z

Ejemplares similares